(Q68916444)
Statements
Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial (English)
H Ludwig
W Scheithauer
B G Van Camp
R Kuzmits
G Fillet
M Peetermans
E Polli
1 September 1986